ArticleNeuroImage2022
Residual RAKI: A hybrid linear and non-linear approach for scan-specific k-space deep learning.
Article in NeuroImage, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Zero-Shot Self-Supervised Learning of Single Breath-Hold Magnetic Resonance Cholangiopancreatography (MRCP) Reconstruction.Magnetic resonance in medicine · 2026Article
- Accelerated RAKI reconstruction for multi-slice cardiac cine applications.Medical physics · 2025Article
- Insights on Scan-Specific Deep-Learning Strategies for Brain MRI Parallel Imaging Reconstruction.NMR in biomedicine · 2025Article
- MRI recovery with self-calibrated denoisers without fully-sampled data.Magma (New York, N.Y.) · 2025Article
- High-efficiency 3D black-blood thoracic aorta imaging with patch-based low-rank tensor reconstruction.Quantitative imaging in medicine and surgery · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Parallel imaging is the most clinically used acceleration technique for magnetic resonance imaging (MRI) in part due to its easy inclusion into routine acquisitions. In k-space based parallel imaging reconstruction, sub-sampled k-space data are interpolated using linear convolutions. At high acceleration rates these methods have inherent noise amplification and reduced image quality. On the other hand, non-linear deep learning methods provide improved image quality at high acceleration, but the availability of training databases for different scans, as well as their interpretability hinder their adaptation. In this work, we present an extension of Robust Artificial-neural-networks for k-space Interpolation (RAKI), called residual-RAKI (rRAKI), which achieves scan-specific machine learning reconstruction using a hybrid linear and non-linear methodology. In rRAKI, non-linear CNNs are trained jointly with a linear convolution implemented via a skip connection. In effect, the linear part provides a baseline reconstruction, while the non-linear CNN that runs in parallel provides further reduction of artifacts and noise arising from the linear part. The explicit split between the linear and non-linear aspects of the reconstruction also help improve interpretability compared to purely non-linear methods. Experiments were conducted on the publicly available fastMRI datasets, as well as high-resolution anatomical imaging, comparing GRAPPA and its variants, compressed sensing, RAKI, Scan Specific Artifact Reduction in K-space (SPARK) and the proposed rRAKI. Additionally, highly-accelerated simultaneous multi-slice (SMS) functional MRI reconstructions were also performed, where the proposed rRAKI was compred to Read-out SENSE-GRAPPA and RAKI. Our results show that the proposed rRAKI method substantially improves the image quality compared to conventional parallel imaging, and offers sharper images compared to SPARK and ℓ
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.